EIF2AK2 Antikörper (AA 224-502)
Kurzübersicht für EIF2AK2 Antikörper (AA 224-502) (ABIN7569196)
Target
Alle EIF2AK2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 224-502
-
Verwendungszweck
- Anti-EIF2AK2 Polyclonal antibody
-
Aufreinigung
- Antigen affinity purification.
-
Immunogen
- E. coli - derived recombinant Human EIF2AK2 (Ser224-Ile502).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
- EIF2AK2 (Eukaryotic Translation Initiation Factor 2-alpha Kinase 2 (EIF2AK2))
-
Andere Bezeichnung
- EIF2AK2
-
Hintergrund
- Protein kinase R,PRKR,Eukaryotic translation initiation factor 2-alpha kinase 2,Interferon-induced,double-stranded RNA-activated protein kinase,Protein kinase RNA-activated,EIF2AK2,Tyrosine-protein kinase EIF2AK2,p68 kinase,PKR,P1/eIF-2A protein kinase,Interferon-inducible RNA-dependent protein kinase,eIF-2A protein kinase 2,
-
UniProt
- P19525
-
Pathways
- DNA Reparatur, ER-Nucleus Signaling, Hepatitis C
Target
-